| Primary |
| Major Depression |
42.1% |
| Hypothyroidism |
15.8% |
| Essential Hypertension |
10.5% |
| Hyperlipidaemia |
10.5% |
| Insomnia |
10.5% |
| Myocardial Infarction |
10.5% |
|
| Hypokalaemia |
33.3% |
| Hypotension |
33.3% |
| Syncope |
33.3% |
|
| Secondary |
| Depression |
34.8% |
| Product Used For Unknown Indication |
19.8% |
| Hypertension |
9.5% |
| Major Depression |
7.9% |
| Diabetes Mellitus |
5.4% |
| Insomnia |
3.0% |
| Maternal Exposure During Pregnancy |
2.4% |
| Pain |
2.4% |
| Drug Exposure Via Mother |
1.6% |
| Schizophrenia |
1.6% |
| Dementia |
1.4% |
| Hypothyroidism |
1.4% |
| Anxiety |
1.1% |
| Bipolar Disorder |
1.1% |
| Bipolar I Disorder |
1.1% |
| Essential Hypertension |
1.1% |
| Gastritis Prophylaxis |
1.1% |
| Hyperlipidaemia |
1.1% |
| Hyperuricaemia |
1.1% |
| Myocardial Infarction |
1.1% |
|
| Somnolence |
9.2% |
| Suicide Attempt |
9.2% |
| Multiple Drug Overdose Intentional |
7.7% |
| Toxicity To Various Agents |
7.7% |
| Vomiting |
7.7% |
| Drug Interaction |
6.2% |
| Body Temperature Increased |
4.6% |
| Breast Enlargement |
4.6% |
| Hyponatraemia |
4.6% |
| Oesophageal Atresia |
4.6% |
| Syncope |
4.6% |
| Tachycardia |
4.6% |
| Cognitive Disorder |
3.1% |
| Condition Aggravated |
3.1% |
| Depression |
3.1% |
| Hallucination, Visual |
3.1% |
| Hypertriglyceridaemia |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Maternal Exposure During Pregnancy |
3.1% |
| Pneumonia |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Depression |
26.4% |
| Pain |
4.2% |
| Hiv Infection |
3.5% |
| Hypertension |
3.5% |
| Diabetes Mellitus |
3.2% |
| Anxiety |
2.9% |
| Borderline Personality Disorder |
2.9% |
| Multiple Sclerosis |
2.9% |
| Insomnia |
2.6% |
| Prostate Cancer |
2.6% |
| Parkinson's Disease |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Schizophrenia |
1.9% |
| Analgesic Therapy |
1.6% |
| Atrial Fibrillation |
1.6% |
| Epilepsy |
1.6% |
| Osteoporosis |
1.6% |
| Schizoaffective Disorder |
1.6% |
| Glycogen Storage Disease Type Ii |
1.3% |
|
| Urticaria |
11.7% |
| Myopathy Toxic |
10.0% |
| Completed Suicide |
8.3% |
| Pneumonia |
6.7% |
| Serotonin Syndrome |
6.7% |
| Rhabdomyolysis |
5.0% |
| Weight Decreased |
5.0% |
| Withdrawal Syndrome |
5.0% |
| Wrong Technique In Drug Usage Process |
5.0% |
| Anxiety |
3.3% |
| Brain Malformation |
3.3% |
| Cervical Dysplasia |
3.3% |
| Deafness |
3.3% |
| Depression |
3.3% |
| Diarrhoea |
3.3% |
| Drug Interaction |
3.3% |
| Haematochezia |
3.3% |
| Oedema |
3.3% |
| Overdose |
3.3% |
| Personality Disorder |
3.3% |
|
| Interacting |
| Blood Cholesterol Increased |
17.6% |
| Depression |
17.6% |
| Gastrooesophageal Reflux Disease |
17.6% |
| Insomnia |
17.6% |
| Bipolar I Disorder |
11.8% |
| Atrial Fibrillation |
5.9% |
| Hypertension |
5.9% |
| Myeloproliferative Disorder |
5.9% |
|
| Gait Disturbance |
33.3% |
| Mania |
22.2% |
| Drug Interaction |
11.1% |
| Hyponatraemia |
11.1% |
| Suicidal Ideation |
11.1% |
| Therapeutic Response Decreased |
11.1% |
|
